The company has reported total income of Rs.129.14 crores during the period ended December 31, 2022 as compared to Rs.157.54 crores during the period ended December 31, 2021.
The company is in the process of appointing the new Chief Financial Officer shortly and in the interim, Komal Gupta will continue as CFO
Zidavi is recommended by the Infectious Disease Society of America
This clearance allows the company to initiate a clinical trial for patients with an ileal pouch-anal anastomosis
This donation will allow the continuation of the cycle of vaccination for children foreseen within the national immunization program carried out by the Ministry of Public Health of Cuba
There have been reports from Uzbekistan concerning contaminated cough syrup Dok1 Max made by Indian company Marion Biotech, Noida, Uttar Pradesh
The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
The company will reduce wastage substantially, increase productivity, enhance environmental consciousness, save energy, optimally use natural resources, and expand its market penetration
Subscribe To Our Newsletter & Stay Updated
